Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the ability of Rituximab maintenance therapy to
prolong progression free survival in patients with chronic lymphocytic leukemia, who
responded to a Rituximab induction therapy.